Summary
Chronic administration of lithium displays therapeutic and prophylactic effects in bipolar affective disorders, but its mechanism of action remains unknown. Several studies in animals and humans strongly suggest that central serotonergic neurons might be involved in lithium effects. In the experiments reported here microdialysis with removable probes and high pressure liquid chromatography and electrochemical detection were used to assess the amphetamine-induced release of serotonin (5-HT) and the 5-hydroxy-indoleacetic acid (5-HIAA) levels in the perifornical hypothalamus (PFH) and hippocampus (HP) of freely moving rats before and after chronic lithium chloride administration (2 meq/kg, as intragastric daily injections for 14 days). The serum lithium levels were 0.66 ± 0.08 meq/1. After lithium treatment, the amphetamine-induced 5-HT release was significantly enhanced in the PFH but not so in the HP. Basal levels of 5-HIAA in the control group decreased but remained unchanged in the lithium group in the PFH. No change of basal levels of 5-HIAA was observed in the HP. The effect of lithium on the PFH could be related to the improvement of the autonomic and cyclic symptoms of patients with manic depressive disorders undergoing lithium therapy.
Similar content being viewed by others
References
Auerbach S, Lipton P (1985) Regulation of serotonin release from the in vitro rat hippocampus: effects of alterations in levels of depolarization and in rates of serotonin metabolism. J Neurochem 44: 1116–1130
Abou-Saleh MT (1987) Prophylaxis of recurrent mood disorders. In: Depression and mania: modern lithium therapy. IRL Press Ltd, Oxford, pp 38–40
Blier P, De Montigny C (1985) Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. Eur J Pharmacol 113: 69–77
Bunney WE, Garland BL (1983) Possible receptors effects of chronic lithium administration. Neuropharmacology 22: 367–372
Ellison G, Eison M, Huberman H, Daniel F (1978) Long term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201: 276–278
Fuller R, Hemrick-Luecke S (1980) Long lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209: 305–307
Grof P, Lane J (1984) Lithium: current issues. Prog Neuropsychopharmacol Biol Psychiatry 8: 539–540
Hernández L, Páez X, Hamlim C (1983a) Neurotransmitters extraction by local cerebral dialysis in anesthetized rats. Pharmacol Biochem Behav 18: 159–162
Hernández L, Parada MA, Hoebel BG (1983b) Amphetamine-induced hyperphagia and obesity caused by intraventricular or lateral hypothalamic injections in rats. J Pharmacol Exp Ther 227: 524–530
Hernández L, Stanley BG, Hoebel BG (1986) A small, removable microdialysis probe. Life Sci 39: 2629–2637
Hernández L, Lee F, Hoebel BG (1987) Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res Bull 19: 623–628
Hernández L, Hoebel BG (1989) Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res Bull 22: 763–769
Hotta I, Yamawaki S, Segawa T (1986) Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain. Neuropsychobiology 16: 19–26
Katz RI, Chase TN, Kopin IJ (1968) Evoked release of norepinephrine and serotonin from brain slices: inhibition by lithium. Science 162: 466–467
König JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams and Wilkins, Baltimore
Maggi A, Enna DS (1980) Regional alterations in rat brain neurotransimtter system following chronic lithium treatment. J Neurochem 34: 645–647
Müller-Oerlinghausen B (1985) Lithium long-term treatment: does it act via serotonin? Pharmacopsychiatry 18: 214–217
Parada MA, Hernandez L, Schwartz D, Hoebel BG (1988) Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine. Physiol Behav 44: 607–610
Rocs BF, Sherwood RA, Riley C (1982) Direct determination of therapeutic concentrations of lithium in serum by flow-injection analysis with atomic absorption spectroscopic detection. Clin Chem 28: 440–443
Rosenthal NE, Godwin FK (1982) The role of the lithium ion in medicine. Ann Rev Med 33: 559
Sachar EJ (1985) Disorders of feeling: affective disorders. In: Principles of neural science. Elsevier, North-Holland New York, pp 718–727
Shaw DM (1975) Lithium and amine metabolism. In: Johnson FN (ed) Lithium research and therapy. Academic Press, London, pp 411–423
Schou M, Juel-Nielson N, Stromgren E (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17: 250–260
Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213: 1529–1531
Waldmeier PC (1987) Is there a common denominator for the antimanic effect of lithium and anticonvulsants? Pharmacopsychiatry 20: 37–47
Walker RG, Kincaid-Smith P (1987) Kidney and the fluid regulatory system. In: Johnson FN (ed) Depression and mania: modern lithium therapy. IRL Press, Oxford, pp 206–212
Wang H, Friedman E (1988) Chronic lithium: desensitization of autoreceptors mediating serotonin release. Psychopharmacology 94: 312–314
Weiger WA, Bear DM (1988) An approach to the neurology of aggression. J Psychiatr Res 22: 85–98
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baptista, T.J., Hernández, L., Burguera, J.L. et al. Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study. J. Neural Transmission 82, 31–41 (1990). https://doi.org/10.1007/BF01244832
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244832